July 18, 2007 - Abiomed Inc. announced that its Impella 2.5 and Impella 5.0 circulatory support technologies, new catheter-based circulatory support technology for heart failure patients, have been approved for use in Canada by Health Canada's Therapeutic Products Programme (TPP). In addition, the Company also announced that the first patients in Canada have received treatment with the Impella 2.5 technology at the Peter Munk Cardiac Centre at Toronto General Hospital.

July 18, 2008 - Cardium Therapeutics announced that the FDA has given it clearance for fast track designation to its lead product candidate, Generx (alferminogene tadenovec, Ad5FGF-4), designed to treat myocardial ischemia.

July 18, 2007 - Cardium Therapeutics and its operating unit, InnerCool Therapies, have released its new CoolBlue surface temperature modulation system and RapidBlue endovascular temperature modulation system used for temperature modulation therapy in cardiac arrest patients.

July 18, 2007 - In a related study of over 25,000 initially healthy women, higher triglyceride levels measured after not fasting is associated with an increased risk for cardiovascular events, but his association was not found for triglyceride levels measured after fasting, according to a study in the July 18 issue of JAMA.

July 18, 2007 - An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated with radiation exposure from a computed tomography (CT scan) coronary angiography varies widely, with the risk greater for women and younger patients, according to a study in the July 18 issue of JAMA.

Cardium Therapeutics and its operating unit, InnerCool Therapies, have released its new CoolBlue surface temperature modulation system for temperature modulation therapy in cardiac arrest patients.

July 17, 2007 – LDS Hospital will become certified to implant the CardioWest temporary Total Artificial Heart (TAH-t), the first and still only FDA approved temporary total artificial heart in the world.
Cardiothoracic surgeon Stephen Clayson, M.D., and his heart transplant team from LDS Hospital in Utah, are at at University Medical Center in Tucson, receiving the first phase of certification training to implant the TAH-t. The remaining three phases of TAH-t certification training take place at the hospital being certified.

July 17, 2007 - Boston Scientific Corp. today announced the implantation of its TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System (TAXUS Petal Stent) in a patient in New Zealand, marking the beginning of the TAXUS PETAL I First Human Use (FHU) Trial, evaluating the safety of a dedicated bifurcation paclitaxel-eluting stent platform for the treatment of coronary artery disease.

July 17, 2007 - Heart Imaging Technologies (HeartIT) announced today that medical images can be viewed on Apple’s new iPhone.

July 17, 2007 - Medtronic Inc. announced launch of Reveal XT, an Insertable Cardiac Monitor that features long-term and continuous monitoring of Atrial Fibrillation (AF), in the European market as it recently received CE (Conformité Européenne) Mark.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now